Edwards Lifesciences Corp. (EW)

135.64
NYSE : Health Technology
Prev Close 133.67
Day Low/High 133.01 / 135.69
52 Wk Low/High 89.20 / 138.48
Avg Volume 1.38M
Exchange NYSE
Shares Outstanding 210.02M
Market Cap 28.20B
EPS 2.80
P/E Ratio 49.51
Div & Yield N.A. (N.A)

Latest News

Edwards Lifesciences Achieves #54 Analyst Rank, Surpassing Snap-On

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Edwards Lifesciences Corp has taken over the #54 spot from Snap-On, Inc. , according to ETF Channel.

Cramer: 10 Points to Consider

Cramer: 10 Points to Consider

Don't worry about missing anything, we haven't solved the bond conundrum and the evidence says we get to 3% with selloffs on the way.

7 Investment Themes You Can't Afford to Miss for 2018

7 Investment Themes You Can't Afford to Miss for 2018

The 'winning formula' for this year focuses on growth, size and foreign stocks, Jefferies says.

Marvell Technology, Albemarle, Dominion Energy: 'Mad Money' Lightning Round

Marvell Technology, Albemarle, Dominion Energy: 'Mad Money' Lightning Round

Jim Cramer is bullish on Marvell Technology, Albemarle, Dominion Energy, Best Buy, Houlihan Lokey.

Consumers Are Ready to Spend: Cramer's 'Mad Money' Recap (Tuesday 1/9/18)

Consumers Are Ready to Spend: Cramer's 'Mad Money' Recap (Tuesday 1/9/18)

Jim Cramer explains why some retailers are doing so well and how investors can take advantage of the opportunities.

Edwards Lifesciences' Board Approves New $1 Billion Share Repurchase Program

Edwards Lifesciences' Board Approves New $1 Billion Share Repurchase Program

Company Also Enters Into Accelerated Share Repurchase Agreement

Edwards Acquires Harpoon Medical

Edwards Acquires Harpoon Medical

What it Takes to Power This Bull: Cramer's 'Mad Money' Recap (Thursday 11/30/17)

What it Takes to Power This Bull: Cramer's 'Mad Money' Recap (Thursday 11/30/17)

Lose the cynicism or you might miss the move. Jim Cramer outlines the reasons for these gains and why investors need to watch them.

Medtronic's Strong Q1 Helps Send Healthcare Stocks Higher

Medtronic's Strong Q1 Helps Send Healthcare Stocks Higher

The Health Care SPDR ETF (XLV) was rising nearly 1% in afternoon trading on Tuesday, boosted in part, by solid results from medical equipment company Medtronic.

Ollie's Bargain Outlet, Blackstone Group: 'Mad Money' Lightning Round

Ollie's Bargain Outlet, Blackstone Group: 'Mad Money' Lightning Round

Jim Cramer is bullish on Ollie's Bargain Outlet, Burlington Stores, Blackstone Group, and UnitedHealth Group.

Can You Recognize Growth?: Cramer's 'Mad Money' Recap (Tuesday 10/31/2017)

Can You Recognize Growth?: Cramer's 'Mad Money' Recap (Tuesday 10/31/2017)

Jim Cramer says the world's been starved for growth for ages, so suspend your disbelief and don't miss out on this economic opportunity.

Edwards SAPIEN 3 Transcatheter Valve Demonstrates Significant Cost Savings Over Surgery In Intermediate Risk Patients

Edwards SAPIEN 3 Transcatheter Valve Demonstrates Significant Cost Savings Over Surgery In Intermediate Risk Patients

Lower costs with transcatheter valve driven by shorter lengths of stay, simpler procedures, fewer hospitalizations and rehab days

String of Disappointing Earnings Leads Markets Into the Red

String of Disappointing Earnings Leads Markets Into the Red

Several firms reported both top and bottom line third-quarter misses, as the three major U.S. averages remain in the red on Wednesday.

12 Stocks This Top Research Firm Wants You to Buy Now

12 Stocks This Top Research Firm Wants You to Buy Now

These are the 12 best investment selections from Fundstrat that may provide investors with 'timely' long-term potential.

Edwards Lifesciences, AeroVironment, Oshkosh Truck: 'Mad Money' Lightning Round

Edwards Lifesciences, AeroVironment, Oshkosh Truck: 'Mad Money' Lightning Round

Jim Cramer is bullish on Edwards Lifesciences, AeroVironment, Oshkosh Truck, Albemarle and more.

Beware This Bull Stampede: Cramer's 'Mad Money' Recap (Tuesday 10/3/17)

Beware This Bull Stampede: Cramer's 'Mad Money' Recap (Tuesday 10/3/17)

Jim Cramer says that with the exception of the department stores and the oils, a case can be made for almost anything in this market.

Edwards Lifesciences: Cramer's Top Takeaways

Edwards Lifesciences: Cramer's Top Takeaways

Mike Mussallem, chairman and CEO of Edwards Lifesciences, tells Jim Cramer about his company's heart-valve advancements.

Don't Let Stock Picking Scare You: Cramer's 'Mad Money' Recap (Wednesday 7/19/17)

Don't Let Stock Picking Scare You: Cramer's 'Mad Money' Recap (Wednesday 7/19/17)

Jim Cramer says do your homework, be informed and don't let the wise guys trip you up with their warnings about 'single-stock risk.'

TheStreet Quant Rating: B (Buy)